Could Chewing Gum Speed Recovery Following Cesarean Section?
BACKGROUND AND PURPOSE:
Chewing gum has been proven to accelerate return of bowel function in abdominal and gynecologic surgery
Ciardulli et al. (Journal of Maternal-Fetal & Neonatal Medicine., 2018) sought to determine whether chewing gum accelerates the return of gastrointestinal function after cesarean delivery
Systematic review and meta-analysis
RCTs comparing chewing gum vs control group
Participants: Women in the immediate postoperative period following cesarean section
Patients received either
Chewing gum: 3 times a day for 30 min each until first flatus
Time to first flatus (in hours)
Time to first bowel sounds | Length of hospital stay | Time to first feces | Maternal satisfaction | First feeling of hunger | Number of episodes of nausea or vomiting after cesarean | Need for additional analgesics or antiemetics | Incidence of paralytic ileus
Seventeen trials were included
Total of 3041 women
Majority of women had planned cesarean sections
The chewing gum group had a significantly lower mean time to
First flatus: Mean difference (MD) -6.49 h (95% CI, -8.65 to -4.33)
First bowel sounds: MD -8.48 h (95% CI, -9.04 to -7.92)
Stay cessation: MD -0.39 days (95% CI, -0.78 to -0.18)
First feces: MD -9.57 h (95% CI, -10.28 to 8.87)
First feeling of hunger: MD- 2.89 h (95% CI -4.93 to -0.85)
Chewing gum group also had
Less number of episodes of nausea or vomiting: Relative risk (RR) 0.33 (95% CI, 0.12 to 0.87)
Less incidence of ileus: RR 0.39 (95% CI, 0.19 to 0.80)
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan